153 related articles for article (PubMed ID: 32513976)
21. Assessment of soluble skin surface protein levels for monitoring
Orro K; Salk K; Abram K; Arshavskaja J; Meikas A; Karelson M; Neuman T; Kingo K; Spee P
Front Med (Lausanne); 2023; 10():1072160. PubMed ID: 36936209
[TBL] [Abstract][Full Text] [Related]
22. Study of serum levels and skin expression of S100B protein in psoriasis.
Salem SAM; El-Khateeb EA; Harvy M; Emam HME; Abdelaal W; Nemr RE; El-Hagry OO
An Bras Dermatol; 2017; 92(3):323-328. PubMed ID: 29186242
[TBL] [Abstract][Full Text] [Related]
23. Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial.
Liu M; Li X; Chen XY; Xue F; Zheng J
Dermatol Ther; 2015; 28(6):373-82. PubMed ID: 26286610
[TBL] [Abstract][Full Text] [Related]
24. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
[TBL] [Abstract][Full Text] [Related]
25. Role of CYR61 in psoriatic lesional and perilesional skin: A clinical and immunohistochemical study.
Shehata WA; Maraee AH; Abdo EE; Hemida AS
J Cosmet Dermatol; 2021 Sep; 20(9):2981-2988. PubMed ID: 33484099
[TBL] [Abstract][Full Text] [Related]
26. Significant Changes in the Skin Microbiome in Patients with Chronic Plaque Psoriasis after Treatment with Narrowband Ultraviolet B.
Assarsson M; Duvetorp A; Dienus O; Söderman J; Seifert O
Acta Derm Venereol; 2018 Apr; 98(4):428-436. PubMed ID: 29199351
[TBL] [Abstract][Full Text] [Related]
27. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis.
Suárez-Fariñas M; Li K; Fuentes-Duculan J; Hayden K; Brodmerkel C; Krueger JG
J Invest Dermatol; 2012 Nov; 132(11):2552-64. PubMed ID: 22763790
[TBL] [Abstract][Full Text] [Related]
28. Expression of miR-135b in Psoriatic Skin and Its Association with Disease Improvement.
Chicharro P; Rodríguez-Jiménez P; Llamas-Velasco M; Montes N; Sanz-García A; Cibrian D; Vara A; Gómez MJ; Jiménez-Fernández M; Martínez-Fleta P; Sánchez-García I; Lozano-Prieto M; Triviño JC; Miñambres R; Sánchez-Madrid F; de la Fuente H; Dauden E
Cells; 2020 Jul; 9(7):. PubMed ID: 32630692
[TBL] [Abstract][Full Text] [Related]
29. Increased carbonyl protein level in the stratum corneum of inflammatory skin disorders: A non-invasive approach.
Iwai I; Shimadzu K; Kobayashi Y; Hirao T; Etou T
J Dermatol; 2010 Aug; 37(8):693-8. PubMed ID: 20649709
[TBL] [Abstract][Full Text] [Related]
30. Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin.
Pohla L; Ottas A; Kaldvee B; Abram K; Soomets U; Zilmer M; Reemann P; Jaks V; Kingo K
Sci Rep; 2020 Feb; 10(1):3081. PubMed ID: 32080291
[TBL] [Abstract][Full Text] [Related]
31. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid.
Smits T; Robles CA; van Erp PE; van de Kerkhof PC; Gerritsen MJ
J Invest Dermatol; 2005 Oct; 125(4):833-9. PubMed ID: 16185285
[TBL] [Abstract][Full Text] [Related]
32. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity.
Morsy H; Kamp S; Thrane L; Behrendt N; Saunder B; Zayan H; Elmagid EA; Jemec GB
Arch Dermatol Res; 2010 Mar; 302(2):105-11. PubMed ID: 19894055
[TBL] [Abstract][Full Text] [Related]
33. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
[TBL] [Abstract][Full Text] [Related]
34. Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.
Watanabe Y; Yamaguchi Y; Komitsu N; Ohta S; Azuma Y; Izuhara K; Aihara M
Br J Dermatol; 2016 Jun; 174(6):1327-36. PubMed ID: 26822223
[TBL] [Abstract][Full Text] [Related]
35. Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment.
Koga A; Kajihara I; Yamada S; Makino K; Ichihara A; Aoi J; Makino T; Fukushima S; Jinnin M; Ihn H
J Dermatol; 2016 May; 43(5):522-5. PubMed ID: 26507968
[TBL] [Abstract][Full Text] [Related]
36. Automated, computer-guided PASI measurements by digital image analysis versus conventional physicians' PASI calculations: study protocol for a comparative, single-centre, observational study.
Fink C; Uhlmann L; Klose C; Haenssle HA
BMJ Open; 2018 May; 8(5):e018461. PubMed ID: 29773695
[TBL] [Abstract][Full Text] [Related]
37. Reproducible Novel Transcriptional Differences Between Psoriatic Lesional and Non-Lesional Skin Show Increased Inflammation and Metabolism.
Aires DJ; Rockwell G; Menter A; Nielson C; Wick J; Sedivy S; Tawfik O; Bowcock A; Sinha AA
J Drugs Dermatol; 2015 Aug; 14(8):794-800. PubMed ID: 26267723
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 protein in psoriasis.
Baran W; Szepietowski JC; Szybejko-Machaj G
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):79-83. PubMed ID: 16200332
[TBL] [Abstract][Full Text] [Related]
39. Biomolecular index of therapeutic efficacy in psoriasis treated with anti-TNF-α agents.
Bianchi L; Costanza G; Campione E; Ruzzetti M; Di Stefani A; Diluvio L; Giardina E; Cascella R; Cordiali-Fei P; Bonifati C; Chiricozzi A; Novelli G; Ensoli F; Orlandi A
G Ital Dermatol Venereol; 2018 Jun; 153(3):316-325. PubMed ID: 27627098
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Effect of Metabolic Syndrome on the Autophagy Marker LC3 in Psoriasis Vulgaris Patients: A Cross-Sectional Study.
Nada EA; Muhammad EMS; Ahmed SFM; Tamam AMS; Abdelhamed A
Clin Cosmet Investig Dermatol; 2020; 13():1005-1013. PubMed ID: 33376378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
